ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB)

Q1 2017 13F Holders as of 3/31/2017

Type / Class: Equity / Common Stock, par value $0.01 per share
Shares outstanding: 52.3M
Number of holders: 108
Total 13F shares, excl. options: 28.3M
Shares change: +3.8M
Total reported value, excl. options: $237M
Value change: +$32.1M
Number of buys: 47
Number of sells: -44
Price: $8.37

Significant Holders of ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) as of Q1 2017

118 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q1 2017.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 108 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 28.3M shares of 52.3M outstanding shares and own 54.13% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (4.2M shares), Evermore Global Advisors, LLC (3.31M shares), BlackRock Inc. (3.19M shares), RENAISSANCE TECHNOLOGIES LLC (2.04M shares), DIMENSIONAL FUND ADVISORS LP (1.83M shares), VANGUARD GROUP INC (1.67M shares), ACADIAN ASSET MANAGEMENT LLC (1.19M shares), First Light Asset Management, LLC (1.12M shares), GILDER GAGNON HOWE & CO LLC (831K shares), and STATE STREET CORP (583K shares).
This table shows the top 108 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

Investor	Option	Weight %	Change %	Value $	* Price $	Shares	Share Change	Activity	Report Period

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.